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1 Department of Rheumatology and connective tissue diseases, University College London, London, UK Background: SSc is uncommon and pathogenesis is not fully understood, however genetic factors have shown to play a role. SSc has shown evidence of dysregulation of the vascular and immune systems, with end point fibrosis, and fatal vascular complications such as renal crisis. To date, a number of candidate gene studies and Genome-wide association studies (GWAS) have shown the replication of a number of key loci. A variant of rs17384213 SNP in the nitric oxide generating enzyme DDAH1 (Dimethylarginine dimethylaminohydrolase) has previously been reported to be associated with a decline in the renal function during chronic kidney disease. As renal involvement is still a major source of morbidity among SSc patients, we genotyped the previously associated polymorphism in DDAH1 to ascertain if it plays a role in SSc renal crisis. Methods: 728 SSc cases and 260 healthy controls were genotyped for the polymorphism rs17384213 in DDAH1 as part of a larger genotyping study. All patients and controls were of Caucasian decent and were categorized according to three mutually exclusive autoantibody status: anti-topoisomerase1 (ATA), anticentromere (ACA) and antiRNA-polymerase (ARA). Patients were further classified into sub-phenotypes according to major organ involvement; pulmonary hypertension, pulmonary fibrosis and renal crisis. All genotyping was performed by the KASP system (KBioscience, UK). All genotype data and subphenotype analysis was performed using PLINK. Results: Our cohort consisted of 274 (38%) patients with lung fibrosis, 112 (15%) with pulmonary hypertension and 63 (9%) with renal crisis. 255 (35%) patients were positive for ACA, 155 (21%) patients were positive for ATA, and 140 (19%) patients were positive for ARA. Casecontrol and sub-phenotype analysis were performed using PLINK. No association with SSc or sub-phenotypes were found. Conclusion: DDAH1 has previously been reported to be associated with chronic kidney disease through increased expression leading to higher levels of asymmetric dimethylarginine (ADMA), this was therefore a good candidate for further investigation in SSc. However we did not find any association with this SNP in SSc or any sub-phenotype. We therefore conclude that there does not appear to be any genetic link between rs17384213 and scleroderma renal disease, which may add additional support to the current hypothesis that mechanisms of renal disease in SSc are distinct from those determining renal decline in other conditions. This is consistent with previous data showing that histological scores of damage that predict outcome in other chronic kidney disease are not useful in SSc. Confirmation of the lack of association of this SNP in an independent cohort is necessary to verify our findings. Background: RA is characterized by chronic inflammation and angiogenesis within the synovium, leading to deformity, pain, loss of function and disability.
Increasing evidence supports the role of microparticles (MPs) in the development of RA due to their proinflammatory and proangiogenic effects, though recent studies provide evidence both for and against increased numbers of MPs in RA. Transfer of MP contents proffers a mechanism by which MPs could contribute to RA pathogenesis, though no research has yet been conducted into the role of plasma microparticles in RA. Understanding the pathogenesis of this common disease is crucial to developing new therapies to treat or even prevent it. We aimed to investigate the number, cellular origins and expression of miRNAs in MPs in moderately active and severely active RA compared with those from healthy controls. Methods: Twelve patients with mild/moderate RA were selected from an early arthritis clinic. A further 10 patients with severe RA were selected from general rheumatology clinics. Healthy volunteers served as controls. Whole blood samples were collected from each participant, and microparticles isolated by differential centrifugation. Flow cytometry was used to ascertain MP numbers by adding counting beads to MP samples, and to identify surface membrane characteristics by incubating MP samples with annexin V or antibodies recognizing target surface cell markers. Real-time PCR was conducted on the MPs to determine micro RNA content. The results of the severely active RA patients and the mild/moderately active RA patients were then compared with those of the controls. Results: The number of microparticles was increased in RA, with more observed in patients with highly active disease compared with mild/ moderately active disease. Flow cytometric analysis revealed decreased annexin V positivity in MPs in mild/moderate RA, but increased positivity in highly active RA; and determined that there was no difference in the cellular origins of MPs between RA patients and controls. Finally, this study demonstrates that miR-29a and miR-29c (regulators of extracellular matrix genes), as well as miR-181b (an NFkB pathway inhibitor) are significantly up regulated (11.3-, 10.3-, and 5.4-fold respectively) in MPs in highly active RA, but miR-146a (a mediator of inflammation) is significantly down regulated (11.9-fold) in MPs in mild/moderately active RA. Conclusion: In conclusion, this study confirms that total circulating MP number is increased in RA, and that the annexin V positivity of these MPs is decreased in MPs in moderately active RA, but increased in MPs in highly active RA. Moreover, the results provide new evidence of the role of microparticle micro RNAs 29a, 29c, 181b, 126 and 146a in the pathogenesis of RA. Disclosure statement: The authors have declared no conflicts of interest.
JUVENILE SYSTEMIC LUPUS ERYTHEMATOSUS SERUM REDUCES PHAGOCYTIC ACTIVITY OF HEALTHY POLYMORPHONUCLEAR CELLS
Sunil Sampath 1 1 Institute of child health, University of Liverpool, Liverpool, UK Background: Children with lupus have more severe disease onset and greater mortality than adults. Phagocytic function of polymorphonuclear cells (PMNs) is defective in adult-onset SLE, resulting from both cell mediated and humoral factors. There are limited data regarding neutrophil phagocytosis within juvenile-onset SLE (JSLE). This study aimed to analyse the effect of JSLE serum on phagocytic function of PMNs derived from healthy controls. Methods: PMNs were isolated from blood of healthy control subjects within 1 hour of venesection. Phagocytosis was measured using pHrodo labelled E. Coli incubated with isolated PMNs either on ice (negative control) or at 378C for 30 minutes with 10% control and JSLE serum. pHrodo, a pH-sensitive fluorescent dye emits fluorescence at low pH levels occurring post-phagocytic fusion of phagosome with the lysosome, quantified by flow-cytometer. Percentage of PMNs phagocytosing labelled E. Coli were determined and expressed as mean AES.D. Results: JSLE serum from 6 patients and a total of 10 different clinical episodes were investigated. Mean (S.D.) phagocytosis with JSLE serum i148 Downloaded from https://academic.oup.com/rheumatology/article-abstract/53/suppl_1/i148/1796126 by guest on 22 April 2019
